ABSTRACT
INTRODUCTION
Thyroid nodules are defined as any abnormal growth causing mass in thyroid tissue 1 . Thyroid nodules can be found in 4% to 8% by palpation and in 10% to 40% by ultrasound study 2 . Thyroid cancer is more common than all other endocrine cancers with increasing incidence worldwide 3, 4 . The most prevalent types of thyroid malignancies are the differentiated types, papillary and follicular malignancies 1 . Clinically there are simple characteristics that are known to be risky regarding malignancy including male sex, age below 30 y and above 60y, family history of previous thyroid malignancy, previous exposure to neck irradiation and a hard nodule that may cause compression symptoms5. Being noninvasive and inexpensive tool, the ultrasound became the most frequently used imaging test in evaluating the thyroid gland 6, 7 . In addition to clinical assessment, ultrasound helps to identify risky nodules with risky criteria like micro-calcifications, hypo-echoic pattern, illdefined edged nodules and solid pattern 8 . Nowadays, fine needle aspiration biopsy (FNAB)
is considered as the gold standard for diagnosis of thyroid malignancy, but unfortunately about 25% of its biopsies are non-diagnostic 9 . Recently, Thyroid stimulating hormone (TSH)
is considered as a predictor of malignancy in thyroid nodules in many studies. Studies reported a relation between TSH and malignancy as the TSH promotes thyroid cells proliferation 10, 11 .
Most studies focused on single risks predicting the incidence of thyroid malignancy which is not satisfactory, so our study aims to detect different predictors together using clinical, laboratory and radiological assessment.
PATIENTS AND METHODS
This prospective study was carried on at the department of surgery, Faculty of Medicine, Menoufia University on 150 patients suffering from thyroid nodule(s), after obtaining an informed consent from all patients. We excluded all patients with previous surgery of thyroid cancer and those with previous cervical lymph node biopsy. All patients were evaluated in regards to full clinical assessment: (history, physical examination).
Laboratory data: in the form of Thyroid stimulating hormone(TSH), Tri-iodo-thyronin(T3), Thyroxine(T4) using Vidas 30-Biomerieux-United States of America. Imaging data were done on a Philips iU22 ultrasound (US) machine, with a high frequency 7.5-10 MHs probe, color and power Doppler of frequency 4-7 MHs. The solitary and the largest nodule in case of MNG were evaluated by ultrasound, the following criteria were included; number, maximum diameter of the nodule, calcifications (micro-macro), echogenicity, margins (ill defined-well defined), consistency (solid, cystic, mixed), vascularity and suspicious lymph nodes. All patients underwent FNAC and then were classified according to the Bethesda system into BI, BII, BIII, BIV, BV, BVI. All patients underwent surgery (total, subtotal and lobectomy) then the final pathology reports were analyzed. Approval to undertake the study was received from the Menoufia Research and Ethics committee.
Statistical analysis
Data were collected in tables then analyzed in regarding to Chi square (χ2) and p value. P values less than 0.05 were considered significant.
RESULTS
Out of 150 patients included in our study there were 122 females and 28 males.
The mean age of females was 41 years and for males was 38 combining age to gender in different age groups there was no significant difference (Table1 Clinically there are simple characteristics that are known to be risky regarding malignancy including male sex, age below 30 y and above 60y, family history of previous thyroid malignancy, previous exposure to neck irradiation and a hard nodule that may cause compression symptoms 5 . The most prevalent types of thyroid malignancies are the differentiated types, papillary and follicular malignancies 13, 14 .
In is equal in both STN and MNG 15 . The difference in the reported rates of malignancy among patients with STN and MNG in the above studies undoubtedly reflects difference in the selection criteria used for analysis, as well as geographic differences in the population studied 16 .
In the present study. no significant difference in age was found between patients with benign disease and those with malignant disease. The median age was 41 years and 40 years, respectively. Witczac et al (2016), reported similar results which is in accordance with our study 18 . Recent studies reported that most thyroid malignancies occur in the middle age group 20-60y 17, 18 .
In this study men had a higher incidence of malignancy than females with a significant difference (p=0.02). A recent study reported similar data with high incidence of malignancy in males 1 9. On the other hand, Paul et al (2017) reported that incidence of malignancy is higher in females 16 . Other studies reported that there is no significant difference between both sexes regarding the incidence of malignancy 18, 20, 21 . However, after combining age to sex the significance was lost suggesting that sex is not a strong independent predictor of malignancy. This difference between studies may be due to geographic differences and the number of population studied.
In our study only 13 patients recorded as smokers with three patients had malignant nodules all of them were males with no statistical value. Other study reported that smoking decreases the risk of papillary carcinoma through increasing sympathetic discharge and increase in T3, T4 levels and accordingly decrease in TSH levels which is a risk factor in papillary carcinoma 22 .
Though history of previous radiation exposure and presence of family history of thyroid cancer are well established thyroid cancer risk factors that even affect the decision for FNA biopsy of thyroid nodule more than the nodule size itself 12, 21 . No significant difference could be detected regarding family history of thyroid cancer. previous radiation exposure. or history of previous thyroid surgery in the present study. None of the patients in this study had hoarseness of voice. Some patients had dysphagia, dyspnea with no statistically significant value.
The imaging modality of choice for the investigation of thyroid nodule is high resolution US, which has been proven to be an important, cost-effective, simple, safe and accurate method for triaging patients with thyroid nodules either to surgical intervention or follow-up 23 .
In this study out of 30 cases with macro-calcifications 15 cases were malignant and 15 cases were benign and out of 18 cases with micro-calcifications there were 15 cases with malignant nodules and only 3 cases with benign nodules on the final histopathology reports with high significant value of micro-calcification in predicting malignancy in thyroid nodules (P=0.0009). Many studies reported that micro-calcifications are considered as an independent predictor of malignancy in thyroid nodules 7, 17, 19, 20 . In this study, ill-defined edges were statistically significant in predicting malignancy. Similar results were reported in literature 17, 19, 20 .
Out of 30 cases with malignant thyroid nodules there were 25 cases with hypoechoic pattern (p=0.004). Paul et al (2017) , reported that hypo-echoic nodules were seen in 82% of malignant cases 16 . Other studies reported similar data 8.24 . On the other hand, Jaheen et al (2017), found that hypo-echoic pattern is not significant in predicting malignancy 19 .
Intra-nodular hyper-vascularity is known to be a risk factor for malignancy in patients with thyroid nodules and reported by several others 12, 24, 25 . In this study the increased intra-nodular vascularity was a significant predictor of malignancy (P=0.003).
Jaheen et al (2017), reported that increased peri-nodular vascularity is more significant predictor of malignancy than intra-nodular vascularity 19 .
Solid composition of thyroid nodules was significant in the current study (p=0.006). Many studies reported similar results 7, 17, 19, 20 . However, a study by Macias et al (2015) reported that the solid nature of the thyroid nodule is not significant predictor of malignancy 26 .
In the current study the size of nodules below 2 cm was statistically significant in predicting malignancy. Cavallo et al (2017) , reported that the risk of malignancy is inversely related to the nodule size 27, 28 . Other studies reported that larger nodules are more liable to have malignancy than smaller nodules 7, 27, 29 .
In the current study, out of 150 patients there were 51 patients with enlarged lymph nodes 12 of them were malignant in the final histopathology reports with nonsignificant p-value (p=0.5). Other studies reported the significance of enlarged lymph nodes as a predictor of malignancy in thyroid nodules 20, 24 . On the other hand Paul et al, (2017),
reported that enlargement of lymph nodes are of low value in predicting malignancy in thyroid nodules 16 .
Fine needle aspiration (FNA) has an essential role in the evaluation of euthyroid patients with thyroid nodule(s). It reduces the rate of unnecessary major thyroid surgery for patients with benign nodules and triages patients with thyroid cancer to appropriate surgery 30 . In the present study, 5 (3%) patients were classified as BI (non-diagnostic or unsatisfactory), which fits in the recommended incidence rate of BI ranging from 2 to 20%, and ideally should be limited to no more than 10% 30. The incidence of malignancy in BI was 0%, many previous studies reported range of malignancy incidence between 1-4 % 12,. 23, 30 . This difference may be due to not all reports made by the same pathologist and not all smears were ultrasound guided. In BII there were 89 patients only one had malignant nodules with 1.1% false negative. The reported false negative rate in literature is low (0-3%) and may reach up to 5% being higher with large nodule (≥ 4 cm) and this matches with the current study results 12, 31 .
There were 18 patients in BIII with 2 (11%) cases had malignant nodules. Other studies reported higher incidence 16-40% 20, 32 . There were 9 patients in BIV with 3 (33%) cases proved to have malignant nodules. The average reported rate of BIV was 17% with a range of 1.2%-25.3%, with malignancy rate of 26% 33 .
The suggested risk of malignancy in BV is 60-75% (30) . In this study there were 7 cases in BV with 5 (71%) cases had malignant nodules. Jaheen et al (2016), reported similar results with incidence of malignancy in 51% of cases belonging to BV 19 .
Regarding BVI there were 21 cases in this group with 19 cases had malignant nodules (PPV 90.5%) with false positive rate of (9.5%). In general, false positive results of BVI in MNG patients, in the literature, found to be ranging from 0.5% to 10% 33 . Similar result was reported by Jaheen et al (2016) . It is remarkable that there were a gradual increase in incidence of malignancy from BII-BVI, with the highest incidence in BVI making this group statistically significant in predicting malignancy in thyroid nodules 19 .
CONCLUSION
There are significant predictors of malignancy in thyroid nodules such as: male gender. solitary nodules. size below 2 cm, micro-calcifications, hypo-echogenic pattern, solid nodules, ill-defined edges and increased intra-nodular vascularity. This will help clinicians to spare more benign cases from surgical interference.
